Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 AUD | -1.45% |
|
+4.62% | +94.29% |
Jun. 26 | Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test | MT |
Jun. 23 | 7,500,000 Ordinary Shares of Cleo Diagnostics Ltd are subject to a Lock-Up Agreement Ending on 23-JUN-2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+94.29% | 29.15M | |
-11.78% | 11.24B | |
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-0.19% | 5.31B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- Cleo Diagnostics Secures US FDA Feedback for Ovarian Cancer Test